Evidence map›Paper›PMID 33875479›Full record

ArticleInfection and immunity2021

CRISPR Interference To Inducibly Repress Gene Expression in Chlamydia trachomatis.

Scot P Ouellette, Emmanuel A Blay, Nathan D Hatch, Laura A Fisher-Marvin

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
8.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Conditional dCas12-Mediated Gene Knockdown and Complementation in Chlamydia.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Infection and immunity · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Complete deletion of theInfection and immunity · 2025
    Article
  15. Article
  16. ThebioRxiv : the preprint server for biology · 2025
    Article
  17. Article
  18. Article
  19. Journal of bacteriology · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Scot P OuelletteDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Emmanuel A Blay *Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Nathan D Hatch *Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Laura A Fisher-MarvinDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
University of Nebraska Medical Center · US

Funding

Development of Tools for Conditional Knockouts in ChlamydiaR21AI141933 · NIAID · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI OUELLETTE, SCOT P · 2019 to 2020
$419k
NIAID NIH HHS R21 AI141933
6 · The paper itself

Abstract

The ability to inducibly repress gene expression is critical to the study of organisms, like Chlamydia, with reduced genomes in which the majority of genes are likely to be essential. We recently described the feasibility of a CRISPR interference (CRISPRi) system to inducibly repress gene expression in Chlamydia trachomatis. However, the initial system suffered from some drawbacks, primarily leaky expression of the anhydrotetracycline (aTc)-inducible dCas9 ortholog and plasmid instability, which prevented population-wide studies (e.g., transcript analyses) of the effects of knockdown. Here, we describe various modifications to the original system that have allowed us to measure gene expression changes within a transformed population of C. trachomatis serovar L2. These modifications include (i) a change in the vector backbone, (ii) the introduction of a weaker ribosome binding site driving dCas9 translation, and (iii) the addition of a degradation tag to dCas9 itself. With these changes, we demonstrate the ability to inducibly repress a target gene sequence, as measured by the absence of protein by immunofluorescence analysis and by decreased transcript levels. Importantly, the expression of dCas9 alone (i.e., without a guide RNA [gRNA]) had minimal impact on chlamydial growth or development. We also describe complementation of the knockdown effect by introducing a transcriptional fusion of the target gene 3' to dCas9. Finally, we demonstrate the functionality of a second CRISPRi system based on a dCas12 system that expands the number of potential chromosomal targets. These tools should provide the ability to study essential gene function in Chlamydia.

Indexed as

Clustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsGene EditingGene Expression Regulation, BacterialBinding SitesChlamydia InfectionsChlamydia trachomatisGene TargetingPlasmidsRibosomesRNA, Guide, CRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsChlamydiaCRISPRiCRISPR interferencegene expressioninducible repression

Identifiers

PMID33875479
PMCPMC8373233
OpenAlexW3154164226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.